Top

Published in:

01-04-2013 | Regional Cancer Therapies

Regional Therapies for Cancer

Authors: T. Clark Gamblin, MD, MS, H. Richard Alexander, MD, Robert Edwards, MD, David L. Bartlett, MD

Published in: Annals of Surgical Oncology | Issue 4/2013

Excerpt

Surgical oncology continues to see the expansion of regional therapies for patients with advanced malignancy. This evolution and advance reaches far beyond cytoreductive surgery with hyperthermic chemoperfusion (CRS-HIPEC) to limb infusion and perfusions as well as isolated liver perfusion and hepatic artery directed therapies. …

Wagner PL, Austin F, Maduekwe U, et al. Extensive cytoreductive surgery for appendiceal carcinomatosis: Morbidity, Mortality, and Survival. Ann Surg Oncol. 2013. doi:10.1245/s10434-012-2791-7.

Turaga KK, Pappas SG, Gamblin TC. Right hemicolectomy for mucinous adenocarcinoma of the appendix: just right or too much? Ann Surg Oncol. 2013. doi:10.1245/s10434-012-2783-7.

Turner KM, Hanna NN, Zhu Y, et al. Assessment of neoadjuvant chemotherapy on operative parameters and outcomes in patients with peritoneal dissemination from high grade appendiceal cancer. Ann Surg Oncol. 2013. doi:10.1245/s10434-012-2789-1.

Low RN, Barone RM, Lee MJ. Surveillance MR Imaging is superior to serum tumor markers for detecting early tumor recurrence in patients with appendiceal cancer treated with surgical cytoreduction and HIPEC. Ann Surg Oncol. 2013. doi:10.1245/s10434-012-2788-2.

Canda AE, Terzi C, Arslan C, et al. Complications and toxicities after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy. Ann Surg Oncol. 2013. doi:10.1245/s10434-012-2853-x.

Votanopoulos KI, Swett K, Blackham AU, et al. Cytoreductive surgery with hyperthermic chemotherapy in peritoneal carcinomatosis from rectal cancer. Ann Surg Oncol. 2013. doi:10.1245/s10434-012-2787-3.

Deraco M, Baratti D, Hutanu I, Bertuli R, Kusamura S. The role of perioperative systemic chemotherapy in diffuse malignant peritoneal mesothelioma patients treated with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy. Ann Surg Oncol. 2013. doi:10.1245/s10434-012-2845-x.

Leinwand JC, Bates GE, Allendorf JD, et al. Body surface predicts plasma oxaliplatin and pharmacokinetic advantages in hyperthermic intraoperative intraperitoneal chemotherapy. Ann Surg Oncol. 2013. doi:10.1245/s10434-012-2790-8.

Pelz JO, Vetterlein M, Grimmig T, et al. Hyperthermic intraperitoneal chemotherapy in patients with peritoneal carcinomatosis: Role of heart shock proteins and dissecting effects of hyperthermia. Ann Surg Oncol. 2013. doi:10.1245/s10434-012-2784-6.

10.

Arrese D, McNally ME, Chokshi R, et al. Extrahepatic disease should not preclude transarterial chemoembolization for metastatic neuroendocrine carcinoma. Ann Surg Oncol. 2013. doi:10.1245/s10434-012-2786-4.

11.

Wong J, Chen YA, Fisher KJ, Zager JS. Isolated limb Infusion in a series of over 100 infusions, a single center experience. Ann Surg Oncol. 2013. doi:10.1245/s10434-012-2782-8.

12.

Shetty G, Beasley GM, Sparks S, et al. Plasma cytokine analysis in patients with advanced extremity melanoma undergoing isolated limb infusion. Ann Surg Oncol. 2013. doi:10.1245/s10434-012-2785-5.

Title: Regional Therapies for Cancer
Authors: T. Clark Gamblin, MD, MS
H. Richard Alexander, MD
Robert Edwards, MD
David L. Bartlett, MD
Publication date: 01-04-2013
Publisher: Springer-Verlag
Published in: Annals of Surgical Oncology / Issue 4/2013
Print ISSN: 1068-9265
Electronic ISSN: 1534-4681
DOI: https://doi.org/10.1245/s10434-013-2873-1

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Regional Therapies for Cancer

Excerpt

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Excerpt

Please log in to get access to this content

Other articles of this Issue 4/2013

Do MRI Reports Contain Adequate Preoperative Staging Information for End Users to Make Appropriate Treatment Decisions for Rectal Cancer?

Complications and Toxicities After Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy

Rectal Cancer and Teaching Hospitals: Hospital Teaching Status Affects Use of Neoadjuvant Radiation and Survival for Rectal Cancer Patients

The Role of Perioperative Systemic Chemotherapy in Diffuse Malignant Peritoneal Mesothelioma Patients Treated with Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy

Should Ductal Carcinoma-in-situ (DCIS) Be Removed from the ASTRO Consensus Panel Cautionary Group for Off-protocol Use of Accelerated Partial Breast Irradiation (APBI)? A Pooled Analysis of Outcomes for 300 Patients with DCIS Treated with APBI

Blurry Boundaries: Do Epithelial Borderline Lesions of the Breast and Ductal Carcinoma In Situ Have Similar Rates of Subsequent Invasive Cancer?